COSCIENS Biopharma Inc. Acquisitiondate Fair Value Of Total Consideration Transferred
COSCIENS Biopharma Inc. (CSCIF) had Acquisitiondate Fair Value Of Total Consideration Transferred of $4.08 million as of 2024-06-03, per its 20-F filed 2026-03-25.
Financial Statements › Notes
ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred · last filed 2026-03-25
- 2024-06-03: Acquisitiondate Fair Value Of Total Consideration Transferred $4.08M.
| Period end | Acquisitiondate Fair Value Of Total Consideration Transferred |
|---|---|
| 2024-06-03 | $4.08M 20-F · filed 2026-03-25 |